Publication Year

Cyr PL, Slawsky KL, Olchanski N, Krasa HB, Goss TF, Zimmer C, Hauptman PJ. 2011. Effect of serum sodium concentration and tolvaptan treatment on length of hospitalization in patients with heart failure. Am J Health Syst Pharm 68(4):328-333; doi: 10.2146/ajhp100217.

Reddick H. Rural schools initiative. Environmental Health Sciences Summer Institute, Austin, TX, 2011.

Staskal DF, Birnbaum LS. 2011. Health effects of brominated flame retardants. In: The Handbook of Environmental Chemistry, vol. 16 — Brominated Flame Retardants. Springer.

Pierce JS, Abelmann A, SpicerLJ, Adams RE, GlynnME, Neier K, Finley BL, Gaffney SH. 2011. Characterization of formaldehyde exposure resulting from the use of four professional hair straightening products. J Occup Environ Hyg 8(11):686–699; doi: 10.1080/15459624.2011.626259. PMID: 22035353.

Kelsh MA, Kucera G, Erdreich L. Meta-analysis of acoustic neuroma and mobile phone use. Presented at BEMS 33rd Annual Meetings, Halifax, Canada, June 12–17, 2011.

Beyer BK, Chernoff N, Danielsson BR, Davis K -Bruno, Harrouk W, Hood RD, Janer G, Wändel Liminga U, Kim J, Rocca M, Rogers JM, Scialli AR. 2011. Maternal toxicity and its impact on study design and data interpretation. Birth Defects Res B 92(1):36–51; doi: 10.1002/bdrb.20281.

Grace CE, Kim SJ, Rogers JM. 2011. Maternal influences on epigenetic programming of the developing hypothalamic-pituitary-adrenal axis. Birth Defects Res A 91:797–805; doi: 10.1002/bdra.20824.

Lau C, Rogers JM, Desai M, Ross MG. 2011. Fetal programming of adult disease: Implications for prenatal care. Obstet Gynecol 117(4):978–985; doi: 10.1097/AOG.0b013e318212140e.

Wikoff DS, Thompson C, Walker N, DeVito M, Harris M, Birnbaum L, Haws L. Derivation of relative potency estimates using benchmark dose modeling: A case study with TCDF. Presented at Dioxin 2011, Brussels, Belgium, August 2011.

Rowlands JC, Urban JD, Wikoff DS, Budinsky RA. 2011. An evaluation of single nucleotide polymorphisms in the human aryl hydrocarbon receptor-interacting protein (AIP) gene. Drug Metab Pharmacokinet 26(4):431-439; doi: 10.2133/dmpk.DMPK-11-SC-013.

Datta T, Racz L, Kotay SM, Goel R. 2011. Seasonal variations of nitrifying community in trickling filter-solids contact (TF/SC) activated sludge systems. Bioresource Technol 102(3):2272–2279; doi: 10.1016/j.biortech.2010.10.043.

Budinsky R, Urban J, Rowlands JC. 2011. An evaluation of single nucleotide polymorphisms in the human aryl hydrocarbon receptor nuclear translocator gene. Presented at Society of Toxicology 50th Annual Meeting, Washington, DC, March 2011.

Sheehan PJ, Brorby GP, Berman DW, Bogen KT, Holm SE. 2011. Chamber for testing asbestos-containing products: Validation and testing of a re-created chrysotile-containing joint compound.  Ann Occup Hyg 55(7):797-809; doi: 10.1093/annhyg/mer048.

Thompson CM, Grafström RC. 2011. Considerations for the implausibility of leukemia induction by formaldehyde. Toxicol Sci 120(1):230-232; doi: 10.1093/toxsci/kfq340.

Mitchell M, Mehta J, Lau E, Fryzek J. National-level descriptive epidemiology of pediatric acute lymphoblastic leukemia (pALL). Presented at the American Society for Pediatric Hematology Oncology, Baltimore, MD, April 2011

Ceder R, Merne M, Nilsson J-A, Staab C, Höög J-O, Thompson CM, Grafström RC. Toxicogenomic profiling of formaldehyde-exposed normal and transformed human oral keratinocytes. Presented at Society of Toxicology 50th Annual Meeting, Washington, DC, March 2011.

Covington T, Robinson P, Gearhart J. Exploring issues in simulating dermal exposure using a physiologically-based pharmacokinetic-pharmacodynamic (PBPK-PD) model for VX. Poster presented at Society of Toxicology 50th Annual Meeting, Washington, DC, March 2011.

Widner TE, Gaffney SH, Panko JM, Unice KM, Burns AM, Kreider ML, Marshall JR, Booher LE, et al. 2011. Airborne concentrations of benzene for dock workers at the ExxonMobil refinery and chemical plant, Baton Rouge, Louisiana, USA (1977-2005). Scand J Work Environ Health 37(2):147-58; doi: 10.5271/sjweh.3128. PMID: 20941467.

Fitzgerald L, Burkhalter B, Urban J, Staskal D, Harris M, Haws L. VOC serum levels in the general U.S. population: An analysis of the 2003-2004 NHANES dataset. Presented at Society of Toxicology 50th Annual Meeting, Washington, DC, March 2011

Sistare FD, Morton D, Alden C, Christensen J, Keller D, Jonghe SD, et al. 2011. An analysis of pharmaceutical experience with decades of rat carcinogenicity testing: Support for a proposal to modify current regulatory guidelines. Toxicol Pathol 39(4):716–744; doi: 10.1177/0192623311406935.